title: Blockade of the PDGFR family together with SRC leads to diminished proliferation of colorectal cancer cells.
abstract: Among the family of receptor tyrosine kinases (RTKs), platelet-derived growth factor receptor (PDGFR) has attracted increasing attention as a potential target of anti-tumor therapy in colorectal cancer (CRC). To study the function of PDGFRβ in CRC cell lines, SW480, DLD-1 and Caco-2 cells showing high PDGFRβ expression were used for receptor down-regulation by small interfering RNA (siRNA) and using the pharmacological inhibitor of PDGFRβ Ki11502. Blockade of PDGFRβ using both approaches led to moderate inhibition of proliferation and diminished activation of the downstream PI3K-signaling pathway in all three cell lines. Surprisingly, incubation with Ki11502 resulted in an arrest of SW480 cells in the G2 phase of the cell cycle, whereas the siRNA approach did not result in this effect. To address this difference, we analyzed the involvement of the PDGFRβ family member c-KIT in Ki11502 effectiveness, but siRNA and proliferation studies in SW480 and DLD-1 cells could not prove the involvement of c-KIT inactivation during Ki11502 treatment. Hence, an RTK activation antibody array on SW480 cells led us to the identification of the non-receptor tyrosine kinase SRC, which is inactivated after Ki11502 treatment but not after the siRNA approach. Further studies using the SRC-specific inhibitor PP2 showed that SRC inhibition upon treatment with the inhibitor Ki11502 is responsible for the observed effects of Ki11502 in SW480 and DLD-1 CRC cells. In summary, our results demonstrate that the inhibition of PDGFRβ alone using siRNA has only moderate cellular effects in CRC cell lines; however, the multi-target inhibition of PDGFRβ, c-KIT and SRC, e.g., using Ki11502, represents a promising therapeutic intervention for the treatment of CRC.
authors.affiliation: Institute of Human Genetics, University Medical Center Göttingen, Germany. silke@kaulfuss.eu
authors.forename: Silke
authors.initials: S
authors.lastname: Kaulfuß
authors.forename: Henning
authors.initials: H
authors.lastname: Seemann
authors.forename: Rovena
authors.initials: R
authors.lastname: Kampe
authors.forename: Julia
authors.initials: J
authors.lastname: Meyer
authors.forename: Ralf
authors.initials: R
authors.lastname: Dressel
authors.forename: Britta
authors.initials: B
authors.lastname: König
authors.forename: Jens-Gerd
authors.initials: JG
authors.lastname: Scharf
authors.forename: Peter
authors.initials: P
authors.lastname: Burfeind
mesh_terms: D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D018938:Caco-2 Cells; D002453:Cell Cycle / Q000187:drug effects / Q000235:genetics; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D015179:Colorectal Neoplasms / Q000201:enzymology* / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D045325:HCT116 Cells; D019073:HT29 Cells; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000235:genetics; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000037:antagonists & inhibitors / Q000235:genetics; D017479:Receptors, Platelet-Derived Growth Factor / Q000037:antagonists & inhibitors* / Q000378:metabolism; D015398:Signal Transduction; D019061:src-Family Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: C529896:Ki11502; D047428:Protein Kinase Inhibitors; D011804:Quinolines; D034741:RNA, Small Interfering; D020797:Receptor, Platelet-Derived Growth Factor beta; D017479:Receptors, Platelet-Derived Growth Factor; D019061:src-Family Kinases
references.citation: Stem Cells. 2012 Mar;30(3):548-60
references.pmid: 22213560
references.citation: Nat Chem Biol. 2007 Dec;3(12):739-44
references.pmid: 18007642
references.citation: Nature. 2001 May 17;411(6835):375-9
references.pmid: 11357145
references.citation: J Pharmacol Exp Ther. 2012 Dec;343(3):617-27
references.pmid: 22935731
references.citation: In Vivo. 1992 Jul-Aug;6(4):325-31
references.pmid: 1520835
references.citation: Am J Pathol. 2008 Feb;172(2):358-66
references.pmid: 18202197
references.citation: Oncotarget. 2010 Nov;1(7):515-29
references.pmid: 21317448
references.citation: Eur J Pharmacol. 2010 Jan 25;626(2-3):186-92
references.pmid: 19818754
references.citation: Oncotarget. 2013 Jan;4(1):118-27
references.pmid: 23435217
references.citation: Int J Cancer. 2006 Dec 1;119(11):2567-74
references.pmid: 16988946
references.citation: Cancer Cell. 2003 May;3(5):439-43
references.pmid: 12781361
references.citation: Blood. 2008 May 15;111(10):5086-92
references.pmid: 18309036
references.citation: Cancer Res. 2002 Sep 1;62(17):4879-83
references.pmid: 12208734
references.citation: Am J Pathol. 2006 Dec;169(6):2054-65
references.pmid: 17148668
references.citation: Nat Cell Biol. 2005 Sep;7(9):870-9
references.pmid: 16113679
references.citation: Annu Rev Biochem. 1988;57:443-78
references.pmid: 3052279
references.citation: Oncotarget. 2011 Mar;2(3):122-34
references.pmid: 21399234
references.citation: N Engl J Med. 2004 Jun 3;350(23):2335-42
references.pmid: 15175435
references.citation: Curr Opin Pharmacol. 2008 Aug;8(4):427-32
references.pmid: 18625340
references.citation: Clin Cancer Res. 2002 May;8(5):994-1003
references.pmid: 12006511
references.citation: Cancer Res. 2005 Nov 15;65(22):10371-80
references.pmid: 16288027
references.citation: Mol Cancer Ther. 2009 Apr;8(4):821-33
references.pmid: 19372555
references.citation: J Cell Physiol. 2011 Oct;226(10):2617-24
references.pmid: 21792920
references.citation: J Natl Cancer Inst. 1996 Aug 21;88(16):1146-51
references.pmid: 8757194
references.citation: Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1544-50
references.pmid: 19028276
references.citation: J Clin Invest. 1993 Jan;91(1):53-60
references.pmid: 7678609
references.citation: Am J Pathol. 1993 Nov;143(5):1377-88
references.pmid: 8238254
references.citation: J Clin Invest. 2006 Oct;116(10):2610-21
references.pmid: 17016557
references.citation: Cancer Res. 2005 May 1;65(9):3707-15
references.pmid: 15867366
references.citation: Clin Colorectal Cancer. 2010 Apr;9(2):89-94
references.pmid: 20378502
references.citation: N Engl J Med. 2004 Jul 22;351(4):337-45
references.pmid: 15269313
references.citation: Cell. 1990 Apr 20;61(2):203-12
references.pmid: 2158859
references.citation: Biochem Cell Biol. 2004 Apr;82(2):263-74
references.pmid: 15060621